코로나바이러스감염병-19 초기 유행의 임상 역학적 특성

키워드

참고문헌 (32)

1. Zhu N, "A novel coronavirus from patients with pneumonia in China, 2019", N Engl J Med, 382, pp.727~733 (2020)
2. Cheng SC, "First case of coronavirus disease 2019(COVID-19)pneumonia in Taiwan", J Formos Med Assoc, 119, pp.747~751 (2020)
3. Kim JY, "The first case of 2019 novel coronavirus pneumonia imported into Korea from Wuhan, China : implication for infection prevention and control measures", J Korean Med Sci, 35, pp.e61~ (2020)
4. Chan JF, "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission : a study of a family cluster", Lancet, 395, pp.514~523 (2020)
5. "WHO director-general's opening remarks at the media briefing on COVID-19" (2020)[URL]
6. Korean Society of Infectious Diseases, "Report on the epidemiological features of coronavirus disease 2019(COVID-19) outbreak in the Republic of Korea from January 19 to March 2, 2020", J Korean Med Sci, 35, pp.e112~ (2020)
7. "Infectious disease alert level" (2020)[URL]
8. "Current COVID-19 outbreak situation" (2020)[URL]
9. Benvenuto D, "The 2019-new coronavirus epidemic : evidence for virus evolution", J Med Virol, 92, pp.455~459 (2020)
10. Kristian G. Andersen, "The proximal origin of SARS-CoV-2", Nature Medicine, 26(4), pp.450~452 (2020), Springer Science and Business Media LLC[DOI]
11. Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
12. Zou L, "SARS-CoV-2 viral load in upper respiratory specimens of infected patients", N Engl J Med, 382, pp.1177~1179 (2020)
13. "Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)" (2020)[URL]
14. Adam J Kucharski, "Early dynamics of transmission and control of COVID-19: a mathematical modelling study", The Lancet Infectious Diseases, 20(5), pp.553~558 (2020), Elsevier BV[DOI]
15. Stephen A. Lauer, "The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application", Annals of Internal Medicine, 172(9), pp.577~582 (2020), American College of Physicians[DOI]
16. Qun Li, "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia", New England Journal of Medicine, 382(13), pp.1199~1207 (2020), Massachusetts Medical Society[DOI]
17. Zunyou Wu, "Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China", JAMA, 323(13), pp.1239~ (2020), American Medical Association (AMA)[DOI]
18. "Field briefing:diamond princess COVID-19 cases" (2020)[URL]
19. "Rapid risk assessment: novel coronavirus disease 2019 (COVID-19)pandemic: increased transmission in the EU/EEA and the UK – sixth update" (2020)[URL]
20. Wei-jie Guan, "Clinical Characteristics of Coronavirus Disease 2019 in China", New England Journal of Medicine, 382(18), pp.1708~1720 (2020), Massachusetts Medical Society[DOI]
21. "The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) — China, 2020" (2020)[URL]
22. "Management guidelines for coronavirus disease-19. version 7-3" (2020)[URL]
23. "Coronavirus disease (COVID-19)technical guidance: laboratory testing for 2019-nCoV in humans" (2020)[URL]
24. "Guidelines for the laboratory diagnosis of COVID-19 in Korea" (2020)[URL]
25. Chu CM, "Role of lopinavir", ritonavir in the treatment of SARS : initial virological and clinical findings, 2004, pp.59, 252~256
26. Bin Cao, "A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19", New England Journal of Medicine, 382(19), pp.1787~1799 (2020), Massachusetts Medical Society[DOI]
27. Yao X, "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)", Clin Infect Dis (2020)[DOI]
28. Mauthe M, "Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion", Autophagy, 14, pp.1435~1455 (2018)
29. Savarino A, "New insights into the antiviral effects of chloroquine", Lancet Infect Dis, 6, pp.67~69 (2006)
30. Gao J, "Breakthrough : chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies", Biosci Trends, 14, pp.72~73 (2020)
31. Holshue ML, "First case of 2019novel coronavirus in the United States", N Engl J Med, 382, pp.929~936 (2020)
32. Cai Q, "Experimental treatment with favipiravir for COVID-19 : an open-label control study", Engineering (2020)[DOI]

관련 논문AI추천